Abingdon HealthABDXF +8.93%49 Current Ratio is 1.91 as of Dec. 2025, which is 12% below its 10-year median of 2.17. GuruFocus rates ABDXF with a GF Score™ of 49/100 and a GF Value™ of $0.21 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Abingdon Health ranks worse than 51.16% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Abingdon Health's current ratio for the quarter that ended in Dec. 2025 was 1.91.
Abingdon Health has a current ratio of 1.91. It generally indicates good short-term financial strength.
The historical rank and industry rank for Abingdon Health's Current Ratio or its related term are showing as below:
ABDXF'
s Current Ratio Range Over the Past 10 Years
Min: 1.03 Med: 2.17 Max: 3.44
Current: 1.91
During the past 8 years, Abingdon Health's highest Current Ratio was 3.44. The lowest was 1.03. And the median was 2.17.
ABDXF's Current Ratio is ranked worse than 51.16% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.96
vs ABDXF: 1.91
Abingdon Health (OTCPK:ABDXF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Abingdon Health Current Ratio Related Terms
Abingdon Health Current Ratio Historical Data
* Premium members only.
The historical data trend for Abingdon Health's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Abingdon Health's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abingdon Health Current Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Current Ratio distribution charts can be found below:
* The bar in red indicates where Abingdon Health's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abingdon Health (ABDXF) has a Current Ratio of 1.91 as of Dec. 2025. This is 12% below median its historical median of 2.17. Over the past decade, Abingdon Health's Current Ratio has ranged from 1.03 to 3.44. According to the industry distribution chart, Abingdon Health ranks #110 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 51.2%.
Is Abingdon Health's Current Ratio too high?
Abingdon Health's current Current Ratio of 1.91 is 12% below median its 10-year median of 2.17. Over the past 10 years, this metric has ranged from a low of 1.03 to a high of 3.44. The Medical Diagnostics & Research industry median Current Ratio is 1.96. Abingdon Health's value of 1.91 is 2.6% below this industry median. Based on the distribution chart, Abingdon Health ranks #110 out of 215 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Abingdon Health has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abingdon Health's Current Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Abingdon Health ranks #110 out of 215 companies for Current Ratio. This places Abingdon Health in the lower half of its industry. The industry median Current Ratio is 1.96. Abingdon Health's value of 1.91 is 2.6% below this benchmark. Historically, Abingdon Health's own Current Ratio has ranged from 1.03 to 3.44 over the past decade. While the company's 10-year median is 2.17 vs. the industry median of 1.96, Abingdon Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 1.96, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abingdon Health's current Current Ratio of 1.91 is 2.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abingdon Health's current Current Ratio is 1.91, which is 12% below median its own 10-year median of 2.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abingdon Health stock overvalued right now?
Based on GuruFocus' analysis, Abingdon Health (ABDXF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.21, compared to a current price of $0.15 — trading 27.4% below its estimated fair value. The current Current Ratio is 1.91, which is 12% below median its 10-year median of 2.17 and 2.6% below the Medical Diagnostics & Research industry median of 1.96. Abingdon Health's overall GF Score™ is 49/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Abingdon Health (ABDXF), the current Current Ratio is 1.91 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abingdon Health (ABDXF) Overvalued in 2026?
Based on GuruFocus' analysis, Abingdon Health stock appears to be undervalued.
The current stock price of $0.15 is trading 27.4% below its estimated GF Value™ of $0.21.
GuruFocus considers Abingdon Health to be Modestly Undervalued.
Key valuation signals for ABDXF:
Current Ratio: 1.91 (12% below median its 10-year median of 2.17)
GF Value™: $0.21 vs. price of $0.15 (27.4% below fair value)
Industry Position: 2.6% below the Medical Diagnostics & Research median (#110 of 215)
No single metric tells the full story. See the ABDXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.
49GF Score
Get the complete analysis for ABDXF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABDXF has been successfully added to your 
